Asthma, Inc.

Seattle, Washington 98115

0 studies enrolling now · 31 studies all time

What they study most

Allergic Rhinitis, Asthma, Atopic Dermatitis, Dermatitis, Atopic, Food Allergy, Gastroesophageal Reflux Disease, PAR, Peanut Allergy, Perennial Allergic Rhinitis, Persistent Allergic Asthma, Seasonal Allergic Rhinitis, Type I Hypersensitivity

Studies at this site

• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
• Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy — Completed
• Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age — Completed
• Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy — Completed
• A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine — Completed
• A Study of ARRY-502 in Patients With Persistent Asthma — Completed
• Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children — Completed
• Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy — Completed
• Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children — Status unconfirmed
• HAL-MPE1 Safety and Tolerability Study — Completed
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers — Completed
• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) — Completed
• Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation — Completed
• A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma — Completed
• Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). — Completed
• Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients — Stopped early
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma — Completed
• Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification — Stopped early
• Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen — Completed
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis — Completed